Logotype for Nuvation Bio Inc

Nuvation Bio (NUVB) Proxy filing summary

Event summary combining transcript, slides, and related documents.

Logotype for Nuvation Bio Inc

Proxy filing summary

10 Apr, 2026

Executive summary

  • Annual Meeting scheduled for May 21, 2026, via live webcast, with record date of March 25, 2026.

  • Stockholders will vote on director elections, ratification of KPMG LLP as auditor, and an advisory say-on-pay vote.

  • Voting instructions provided for online, phone, and mail participation; quorum requirements detailed.

  • Board recommends voting in favor of all proposals.

Voting matters and shareholder proposals

  • Three proposals: election of three directors, ratification of KPMG LLP as auditor for 2026, and advisory approval of executive compensation.

  • Class A and Class B stockholders vote together for two directors; Class B stockholders vote separately for one director.

  • Stockholder proposals for the 2027 meeting must be submitted by December 11, 2026, for inclusion in proxy materials.

Board of directors and corporate governance

  • Board consists of seven members, divided into three classes with staggered three-year terms.

  • Majority of directors are independent per NYSE standards; Dr. Hung serves as Board Chair, Mr. Bazemore as Lead Independent Director.

  • Board committees: audit, compensation, and nominating/corporate governance, each with defined charters and responsibilities.

  • Board and committees met regularly in 2025, with all directors attending at least 75% of meetings.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more